Advanced search
Publication Cover
OncoImmunology Volume 2, 2013 - Issue 4
Submit an article Journal homepage
725
Views
32
CrossRef citations to date
0
Altmetric
Author's View

Interferon α may be back on track to treat acute myeloid leukemia

Evelien L.J.M. Smits Tumor Immunology Group, Laboratory of Experimental Hematology, Vaccine and Infectious Disease Institute, Faculty of Medicine and Health Sciences, University of Antwerp, Antwerp, Belgium; Center for Cell Therapy and Regenerative Medicine, Antwerp University Hospital, Antwerp, BelgiumCorrespondence[email protected]
,
Sébastien Anguille Tumor Immunology Group, Laboratory of Experimental Hematology, Vaccine and Infectious Disease Institute, Faculty of Medicine and Health Sciences, University of Antwerp, Antwerp, Belgium; Center for Cell Therapy and Regenerative Medicine, Antwerp University Hospital, Antwerp, Belgium
&
Zwi N. Berneman Tumor Immunology Group, Laboratory of Experimental Hematology, Vaccine and Infectious Disease Institute, Faculty of Medicine and Health Sciences, University of Antwerp, Antwerp, Belgium; Center for Cell Therapy and Regenerative Medicine, Antwerp University Hospital, Antwerp, Belgium
Article: e23619 | Received 08 Jan 2013, Accepted 14 Jan 2013, Published online: 01 Apr 2013

References

  • Anguille S, Lion E, Willemen Y, Van Tendeloo VF, Berneman ZN, Smits EL. Interferon-α in acute myeloid leukemia: an old drug revisited. Leukemia 2011; 25:739 - 48; http://dx.doi.org/10.1038/leu.2010.324; PMID: 21274002
  • Berneman ZN, Anguille S, Van Marck V, Schroyens WA, Van Tendeloo VF. Induction of complete remission of acute myeloid leukaemia by pegylated interferon-alpha-2a in a patient with transformed primary myelofibrosis. Br J Haematol 2010; 149:152 - 5; http://dx.doi.org/10.1111/j.1365-2141.2009.08029.x; PMID: 19995392
  • Dagorne A, Douet-Guilbert N, Quintin-Roue I, Guillerm G, Couturier MA, Berthou C, et al. Pegylated interferon α2a induces complete remission of acute myeloid leukemia in a postessential thrombocythemia myelofibrosis permitting allogenic stem cell transplantation. Ann Hematol 2013; 92:407 - 9; http://dx.doi.org/10.1007/s00277-012-1560-9; PMID: 22941306
  • Diamond MS, Kinder M, Matsushita H, Mashayekhi M, Dunn GP, Archambault JM, et al. Type I interferon is selectively required by dendritic cells for immune rejection of tumors. J Exp Med 2011; 208:1989 - 2003; http://dx.doi.org/10.1084/jem.20101158; PMID: 21930769
  • Anguille S, Lion E, Tel J, de Vries IJ, Couderé K, Fromm PD, et al. Interleukin-15-Induced CD56(+) Myeloid Dendritic Cells Combine Potent Tumor Antigen Presentation with Direct Tumoricidal Potential. PLoS One 2012; 7:e51851; http://dx.doi.org/10.1371/journal.pone.0051851; PMID: 23284789
  • Papewalis C, Jacobs B, Wuttke M, Ullrich E, Baehring T, Fenk R, et al. IFN-alpha skews monocytes into CD56+-expressing dendritic cells with potent functional activities in vitro and in vivo. J Immunol 2008; 180:1462 - 70; PMID: 18209041
  • Roothans D, Smits E, Lion E, Tel J, Anguille S. CD56 marks human dendritic cell subsets with cytotoxic potential. OncoImmunology 2013; In press http://dx.doi.org/10.4161/onci.23037
  • Benjamin R, Khwaja A, Singh N, McIntosh J, Meager A, Wadhwa M, et al. Continuous delivery of human type I interferons (alpha/beta) has significant activity against acute myeloid leukemia cells in vitro and in a xenograft model. Blood 2007; 109:1244 - 7; http://dx.doi.org/10.1182/blood-2006-02-002915; PMID: 17047156
  • Mesa RA, Li CY, Ketterling RP, Schroeder GS, Knudson RA, Tefferi A. Leukemic transformation in myelofibrosis with myeloid metaplasia: a single-institution experience with 91 cases. Blood 2005; 105:973 - 7; http://dx.doi.org/10.1182/blood-2004-07-2864; PMID: 15388582
  • Kiladjian JJ, Chomienne C, Fenaux P. Interferon-alpha therapy in bcr-abl-negative myeloproliferative neoplasms. Leukemia 2008; 22:1990 - 8; http://dx.doi.org/10.1038/leu.2008.280; PMID: 18843285

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.